Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9277953 | FEMS Immunology and Medical Microbiology | 2005 | 8 Pages |
Abstract
Whatever sophisticated technology is used, we still have to define the meaning of detecting nucleic acids in a given clinical sample. This seems simple in normally sterile anatomical sites but less obvious for example in respiratory specimens for invasive aspergillosis or in blood for candidosis in heavily colonized patients. Additional studies of the kinetics of fungal DNA are needed. The development of real-time technology should improve our knowledge in order to give the clinicians informative clues for making a decision.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stéphane Bretagne, Jean-Marc Costa,